Agile Therapeutics, Inc. - stock earnings
AGRX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -799000 USD | 6.7 million USD |
| 2023Q2 | -3.8 million USD | 5.5 million USD |
| 2023Q1 | -3.6 million USD | 3.8 million USD |
| 2022Q4 | -13.3 million USD | 4.0 million USD |
| 2022Q3 | -22.0 million USD | 3.0 million USD |
| 2022Q2 | -13.0 million USD | 2.1 million USD |
| 2022Q1 | -11.8 million USD | 1.8 million USD |
| 2021Q4 | -23.4 million USD | 1.5 million USD |
| 2021Q3 | -16.8 million USD | 1.3 million USD |
| 2021Q2 | -17.6 million USD | 1.2 million USD |
| 2021Q1 | -17.1 million USD | 116000 USD |
| 2020Q4 | -17.6 million USD | 749000 USD |
| 2020Q3 | -15.5 million USD | ? USD |
| 2020Q2 | -10.8 million USD | ? USD |
| 2020Q1 | -7.9 million USD | ? USD |
| 2019Q4 | -6.0 million USD | ? USD |
| 2019Q3 | -4.4 million USD | ? USD |
| 2019Q2 | -3.5 million USD | ? USD |
| 2019Q1 | -4.7 million USD | ? USD |
| 2018Q4 | -3.8 million USD | ? USD |
| 2018Q3 | -3.8 million USD | ? USD |
| 2018Q2 | -5.3 million USD | ? USD |
| 2018Q1 | -6.8 million USD | ? USD |
| 2017Q4 | -6.2 million USD | ? USD |
| 2017Q3 | -7.1 million USD | ? USD |
| 2017Q2 | -7.4 million USD | ? USD |
| 2017Q1 | -7.5 million USD | ? USD |
| 2016Q4 | -5.2 million USD | ? USD |
| 2016Q3 | -7.8 million USD | ? USD |
| 2016Q2 | -8.4 million USD | ? USD |
| 2016Q1 | -7.3 million USD | ? USD |
| 2015Q4 | -3.9 million USD | ? USD |
| 2015Q3 | -9.4 million USD | ? USD |
| 2015Q2 | -8.5 million USD | ? USD |
| 2015Q1 | -8.5 million USD | ? USD |
| 2014Q4 | -6.8 million USD | ? USD |
| 2014Q3 | -6.4 million USD | ? USD |
| 2014Q2 | -3.7 million USD | ? USD |
| 2014Q1 | 839293 USD | ? USD |
| 2013Q4 | -2.4 million USD | ? USD |
| 2013Q3 | -3.7 million USD | ? USD |
| 2013Q2 | -3.6 million USD | ? USD |
| 2013Q1 | -4.6 million USD | ? USD |
AGRX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -13.9 million USD | 20.0 million USD |
| 2022 | -25.4 million USD | 10.9 million USD |
| 2021 | -76.6 million USD | 4.1 million USD |
| 2020 | -54.7 million USD | 749000 USD |
| 2019 | -18.4 million USD | ? USD |
| 2018 | -19.8 million USD | ? USD |
| 2017 | -28.3 million USD | ? USD |
| 2016 | -28.7 million USD | ? USD |
| 2015 | -30.3 million USD | ? USD |
| 2014 | -16.1 million USD | ? USD |
| 2013 | -14.3 million USD | ? USD |
| 2012 | -23.3 million USD | ? USD |
AGRX
Price: $0.40
52 week price:
Earnings Per Share: -6.71 USD
P/E Ratio: 0.21
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 296349
Ebitda: -6.6 millionMarket Capitalization: 2.5 million